Cardiorespiratory fitness and physical performance after childhood hematopoietic stem cell transplantation: a systematic review and meta-analysis
Research output: Contribution to journal › Review › Research › peer-review
Standard
Cardiorespiratory fitness and physical performance after childhood hematopoietic stem cell transplantation : a systematic review and meta-analysis. / Fridh, Martin Kaj; Simonsen, Casper; Schmidt-andersen, Peter; Nissen, Anne Anker; Christensen, Jesper Frank; Larsen, Anders; Mackey, Abigail L.; Larsen, Hanne Bækgaard; Müller, Klaus.
In: Bone Marrow Transplantation, Vol. 56, No. 9, 2021, p. 2063–2078.Research output: Contribution to journal › Review › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Cardiorespiratory fitness and physical performance after childhood hematopoietic stem cell transplantation
T2 - a systematic review and meta-analysis
AU - Fridh, Martin Kaj
AU - Simonsen, Casper
AU - Schmidt-andersen, Peter
AU - Nissen, Anne Anker
AU - Christensen, Jesper Frank
AU - Larsen, Anders
AU - Mackey, Abigail L.
AU - Larsen, Hanne Bækgaard
AU - Müller, Klaus
PY - 2021
Y1 - 2021
N2 - The effects of childhood hematopoietic stem cell transplantation (HSCT) on key organs can impair cardiorespiratory fitness, muscle strength, and physical performance. We aimed to provide an overview of childhood HSCT survivors’ status on these parameters compared with healthy controls and discuss current insights into clinical risk factors. We performed a systematic search in six scientific databases, including studies published before April 2019 and performed a meta-analysis on cardiorespiratory fitness. Muscle strength and physical performance status were presented narratively. We included ten studies embodying 517 childhood HSCT survivors (mean 17.8 years at follow-up). The meta-analysis (n = 4 studies) showed that childhood HSCT survivors have lower cardiorespiratory fitness compared with healthy controls (Standard mean difference (SMD) −1.32 [95% CI −1–58 to −1.07]; I2 2%, p < 0.00001). Collectively, the studies indicated that childhood HSCT survivors have lower muscle strength (n = 4 studies) and physical performance (n = 3 studies) compared with healthy controls. Childhood HSCT survivors have impaired cardiorespiratory fitness years after ended treatment. Muscle strength and physical performance seem to be impaired, although these measures are insufficiently investigated. Associations between HSCT-specific clinical risk factors and cardiorespiratory fitness, muscle strength, and physical performance are required.
AB - The effects of childhood hematopoietic stem cell transplantation (HSCT) on key organs can impair cardiorespiratory fitness, muscle strength, and physical performance. We aimed to provide an overview of childhood HSCT survivors’ status on these parameters compared with healthy controls and discuss current insights into clinical risk factors. We performed a systematic search in six scientific databases, including studies published before April 2019 and performed a meta-analysis on cardiorespiratory fitness. Muscle strength and physical performance status were presented narratively. We included ten studies embodying 517 childhood HSCT survivors (mean 17.8 years at follow-up). The meta-analysis (n = 4 studies) showed that childhood HSCT survivors have lower cardiorespiratory fitness compared with healthy controls (Standard mean difference (SMD) −1.32 [95% CI −1–58 to −1.07]; I2 2%, p < 0.00001). Collectively, the studies indicated that childhood HSCT survivors have lower muscle strength (n = 4 studies) and physical performance (n = 3 studies) compared with healthy controls. Childhood HSCT survivors have impaired cardiorespiratory fitness years after ended treatment. Muscle strength and physical performance seem to be impaired, although these measures are insufficiently investigated. Associations between HSCT-specific clinical risk factors and cardiorespiratory fitness, muscle strength, and physical performance are required.
U2 - 10.1038/s41409-021-01370-2
DO - 10.1038/s41409-021-01370-2
M3 - Review
C2 - 34155356
VL - 56
SP - 2063
EP - 2078
JO - Bone Marrow Transplantation
JF - Bone Marrow Transplantation
SN - 0268-3369
IS - 9
ER -
ID: 272572812